Derivatives of APF and methods of use

Details for Australian Patent Application No. 2009282625 (hide)

Owner University of Maryland, Baltimore The United States of America, as represented by The Secretary, Department of Health and Human Services

Inventors Keay, Susan K.; Szekely, Zoltan; Kaczmarek, Piotr; Michejda, Christopher

Agent Freehills

Pub. Number AU-A-2009282625

PCT Pub. Number WO2010/022089

Priority 61/089,698 18.08.08 US; 61/161,349 18.03.09 US; 61/142,407 05.01.09 US

Filing date 18 August 2009

Wipo publication date 25 February 2010

International Classifications

A61K 38/14 (2006.01) Medicinal preparations containing peptides - Peptides containing saccharide radicals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/022089 Priority application(s): WO2010/022089

24 March 2011 Alteration of Name

  The name of the applicant has been altered to University of Maryland, Baltimore; The United States of America, as represented by The Secretary, Department of Health and Human Services; United States Department of Veterans Affairs

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282633-Axially nested slide and lock expandable device

2009282619-Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof